Celerion - Company Profile

Translational medicine experts accelerating drug development for global patient impact. This company provides comprehensive early phase and phase two-three clinical research services, including clinical trial design, project management, clinical and medical monitoring, and bioanalytical sciences. Expertise spans PK/PD, immunogenicity, biomarkers, biosimilars, gene therapy, and metabolite profiling. They offer drug development and regulatory affairs support, data management, biometrics, modeling, simulation, protocol development, clinical data sciences, biostatistics, pharmacokinetics/pharmacodynamics, and medical writing. Therapeutic areas include respiratory, metabolic, oncology, biosimilars, vaccines, renal/hepatic insufficiency, and cardiovascular. They conduct safety studies, tobacco risk evaluation, and product labeling studies. Innovations include proprietary platforms. They focus on translating science to medicine, providing actionable data for reliable drug development, and offer volunteer recruitment services. They are agile, innovative, and global, committed to ethical research practices. They also provide bioanalytical data management software.